Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis

Journal of the American Academy of Dermatology

Volumn 65, Issue 1, 2011, Pages 65-68

  Fujita, Yasuyuki ^a   Yoshioka, Naoya ^a   Abe, Riichiro ^a   Murata, Junko ^a   Hoshina, Daichi ^a   Mae, Hirokatsu ^b   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Immuno Diagnostic Laboratory   (Japan)

Author keywords

adverse drug eruption; diagnostic test; granulysin; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

FAS LIGAND; GRANULYSIN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLISTER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CHROMATOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOASSAY; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; STEVENS-JOHNSON SYNDROME;

EID: 79958864621     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.04.042     Document Type: Article

References (11)

1. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
2. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162:1515-20. (Pubitemid 36512833)
3. Murata J, Abe R, Shimizu H. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 2008;122:992-1000.
4. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008;14:1343-50.
5. Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H. Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 2009;151:514-5.
6. Ogawa K, Takamori Y, Suzuki K, Nagasawa M, Takano S, Kasahara Y, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol 2003;33:1925-33. (Pubitemid 37120864)
7. Saigusa S, Ichikura T, Tsujimoto H, Sugasawa H, Majima T, Kawarabayashi N, et al. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma. J Gastroenterol Hepatol 2007;22:1322-7. (Pubitemid 47222651)
8. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007;56:181-200. (Pubitemid 46074234)
9. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-53. (Pubitemid 30637181)
10. Kaspar AA, Okada S, Kumar J, Poulain FR, Drouvalakis KA, Kelekar A, et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 2001;167:350-6. (Pubitemid 32567799)
11. Clayberger C, Krensky AM. Granulysin. Curr Opin Immunol 2003;15:560-5.